In Silico Predictions and In Vivo Results of Drug–Drug Interactions by Ketoconazole and Verapamil on AZD1305, a Combined Ion Channel Blocker and a Sensitive CYP3A4 Substrate

Publisher: John Wiley & Sons Inc

E-ISSN: 2160-7648|5|5|364-373

ISSN: 2160-763X

Source: Clinical Pharmacology In Drug Development, Vol.5, Iss.5, 2016-09, pp. : 364-373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content